Screener
Eton Pharmaceuticals, Inc. ETON Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Eton Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
FAQ
- What is Eton Pharmaceuticals, Inc.'s current ratio?
- Eton Pharmaceuticals, Inc. (ETON) reported current ratio of 1.2× in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s current ratio changed year-over-year?
- Eton Pharmaceuticals, Inc.'s current ratio decreased by 38.8% year-over-year, from 2× to 1.2×.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s current ratio has grown at a -24.7% compound annual growth rate (CAGR), from 6.5× to 1.6×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Eton Pharmaceuticals, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude